PH-Sensitive and mucoadhesive microspheres for duodenum-specific drug delivery system

Drug Development and Industrial Pharmacy

Volumn 37, Issue 7, 2011, Pages 868-874

  Liu, Yue Hua ^a   Zhu, Xi ^a   Zhou, Dan ^a   Jin, Yun ^a   Zhao, Chun Yan ^a   Zhang, Zhi Rong ^a   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Duodenum specific; enteric coating; mucoadhesion; pH sensitive; thiolated chitosan

Indexed keywords

BERBERINE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE MALEATE; MICROSPHERE; THIOLATED CHITOSAN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; DUODENUM; DUODENUM FLUID; DUODENUM ULCER; IN VITRO STUDY; MORPHOLOGY; MUCOADHESION; NONHUMAN; PH; SIMULATION; STOMACH JUICE;

ADHESIVENESS; BERBERINE; CHITOSAN; DRUG DELIVERY SYSTEMS; DUODENAL ULCER; DUODENUM; HUMANS; HYDROGEN-ION CONCENTRATION; INTESTINAL MUCOSA; METHYLCELLULOSE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; TABLETS, ENTERIC-COATED;

EID: 79958759884     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.546801     Document Type: Article

References (29)

1. Sohn N. (1998). Dyspepsia and ulcers. Primary Care Update for OB/GYNS, 5, 24-27 (Pubitemid 28071370)
2. Konorev MR. (2001). Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers. Int J Antimicrob Agents, 17:425-426 (Pubitemid 32401544)
3. Amiji MM. (2007). Tetracycline-containing chitosan microspheres for local treatment of Helicobacter pylori infection. Cellulose, 14, 3-14 (Pubitemid 46486876)
4. Levy SB. (1992). The antibiotic paradox: how miracle drugs are destroying the miracle. New York: Plenum Press Inc
5. Megraud F. (1994). Helicobacter pylori: basic mechanisms to clinical cure. Dordrecht: Kluwer Academic Publishers
6. Brooks FP. (1985). The pathophysiology of peptic ulcer disease. Digest Dis Sci, 11, 15-29
7. Rhodes J, Prestwich CJ. (1966). Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut, 7:509-514
8. Huang Y, Zheng LL, Liu J, Zhang ZR. (2005). Synthesis and characterization of HPMC derivatives as novel duodenum-specific coating agents. Arch Pharm Res, 28:364-369 (Pubitemid 44698758)
9. Chun MK, Cho CS, Choi HK. (2005). Mucoadhesive microspheres prepared by interpolymer complexation and solvent diffusion method. Int J Pharm, 288:295-303
10. Muramatsu N, Kondo T. (1995). An approach to prepare microparticles of uniform size. J Microencapsul, 12:129-136
11. Takishima J, Onishi H, Machida Y. (2002). Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats. Biol Pharm Bull, 25:1498-1502 (Pubitemid 39663176)
12. Sudhakar Y, Kuotsu K, Bandyopadhyay AK. (2006). Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs. J Control Release, 114, 15-40 (Pubitemid 44128620)
13. Gungor S, Okyar A, Erturk-Toker S, Baktir G, Ozsoy Y. (2010). Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes. Drug Dev Ind Pharm, 36:806-813
14. Malaekeh-Nikouei B, Tabassi SAS, Jaafari MR. (2008). Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine. Drug Dev Ind Pharm, 34, 492-498 (Pubitemid 351878688)
15. Park JH, Saravanakumar G, Kim K, Kwon IC. (2010). Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev, 62:28-41
16. Bernkop-Schnürch A, Hornof M, Guggi D. (2004). Thiolated chitosans. Eur J Pharm Biopharm, 57:9-17 (Pubitemid 38058800)
17. Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. (1999). Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm, 180:185-193 (Pubitemid 29238202)
18. Illum L, Farraj NF, Davis SS. (1994). Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res, 11:1186-1189 (Pubitemid 24259861)
19. Takeuchi H, Yamamoto H, Kawashima Y. (2001). Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev, 47:39-54 (Pubitemid 32209231)
20. Wang Y, Wang XB. (2003). China medicinal therapeutics to Helicobacter pylori. China Med Bull, 3, 40-44
21. Hornofa MD, Kasta CE, Bernkop-Schnurch A. (2003). In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates. Eur J Pharm Biopharm, 55, 185-190 (Pubitemid 36299216)
22. Ranga Rao KV, Buri P. (1989). A novel in situ method to test polymer and coated microparticles for bioadhesion. Int J Pharm, 52, 265-270 (Pubitemid 19155935)
23. Anal AK, Stevens WF, Remuñ-Lpez C. (2006). Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin. Int J Pharm, 312:166-173
24. Genta I, Costantini M, Asti A, Conti B, Montanari L. (1998). Influence of glutaraldehyde on drug release and mucoadhesive properties of chitosan microspheres. Carbohyd Polym, 36, 81-88 (Pubitemid 128399581)
25. Marriot C, Hughes, DRL. (1990). Mucus physiology and pathologhy bioadhesion-possibilities and future trends. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH
26. Bernkop-Schnürch A. (2005). Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev, 57:1569-1582 (Pubitemid 41443470)
27. Supe AN, Mathur SK, Parulkar BG, Patankar SK, Samsi AB, Tilve GH. (1986). Assessment of gastric emptying by radio-nuclide study. J Postgrad Med, 32:206-209
28. Eriksen CA, Sadek SA, Cuschieri A. (1988). 24-Hour ambulatory dual gastroduodenal pH monitoring: the role of acid in duodenal ulcer disease. Ann Surg, 208, 702-707 (Pubitemid 19002508)
29. Gray H, Lewis WH. (1918). Anatomy of the human body. Philadelphia: Lea and Febiger